Cargando…
Technology in the management of type 2 diabetes – present status and future prospects
The growing incidence of type 2 diabetes (T2D) is a significant health concern, representing 90% of diabetes cases worldwide. As the disease progresses, resultant insulin deficiency and hyperglycaemia necessitates insulin therapy in many cases. It has been recognised that a significant number of peo...
Autores principales: | Daly, Aideen, Hovorka, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611289/ https://www.ncbi.nlm.nih.gov/pubmed/33950566 http://dx.doi.org/10.1111/dom.14418 |
Ejemplares similares
-
Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial
por: Daly, Aideen B., et al.
Publicado: (2023) -
Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021) -
Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
por: Fuchs, Julia, et al.
Publicado: (2021) -
Publisher Correction: Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021) -
The changing landscape of automated insulin delivery in the management of type 1 diabetes
por: Lakshman, Rama, et al.
Publicado: (2023)